SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Be...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 25, 2024

Dickens Sanomi Academy Celebrates 10 Years of Transforming Lives, Welcomes Michael Boulos and Tiffany Trump-Boulos • Marshalls Launches First-Ever "Good Stuff Style Collective" in Partnership with Celebrity Stylists Molly Dickson, Zerina Akers a • Toyota Charges Up Investment and Jobs in U.S. Manufacturing • Tallarna Wins NYSERDA Award to Stimulate Actionable LMI Building Retrofits • Humana Healthy Horizons Commits $500K to Improve Health of Louisianians • Atlanta Community Food Bank Opens New Community Food Center in Jonesboro • Eiseman Jewels Celebrates Mother’s Day With Two Designer Trunk Shows • RED NOSE DAY'S ALL-NEW, FUN AND FREE RED NOSE SOCIAL FILTER IS AVAILABLE NOW; USERS CAN SHARE A DIGITAL DOSE OF LAUGHTER FOR GOO • Parsec’s Double Award Win Showcases Dedication to Customers and Manufacturing Expertise • NTT DATA Introduces Sustainable Device-as-a-Service • The Bronx Social Care Network looks to become a lead entity among New York State-funded Social Care Networks • Uforia unites artists, communities nationwide to support St. Jude Children’s Research Hospital this Dia del Niño • ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO • Palm Smashes Preorder Goal for Flagship Smart Compost Bin on First Day • BioInnovation Institute & Science announce the launch of the Translational Medicine Prize for Innovations in Women´s H • Shoreline Equity Partners Announces Investment in Prime Meats • Thirty Madison's Nurx and Cove partner with Talkspace to expand mental health support for more than half a million women • Prudential Financial empowers young changemakers with $15,000 each at Emerging Visionaries Summit • TheXPlace and Unity Kick-off Summer Game Jam • Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report

SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in Spectrum Pharmaceuticals, Inc. and Ad

LOS ANGELES , December 06 /Businesswire/ - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. (“Sepctrum” or “the Company”) (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between December 6, 2021 and September 22, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before February 3, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Spectrum claimed to investors that the ZENITH20 trial of poziotinib showed positive results for safety and efficacy. The Company also claimed it had begun a phase 3 study to confirm the results. This claim was not true, a fact uncovered when the FDA released a briefing document before meeting the Company regarding poziotinib. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Spectrum, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.